A leading precision medicine company, ArteraAI develops AI-enabled tests to help personalize therapy for cancer patients.
Menlo Park, CA
- Tweets 676
- Following 152
- Followers 631
- Likes 119
Dr. Daniel Spratt on Artera’s Post‑RP test:
“[It] uses clinical and pathologic features + digital pathology, running AI to help ID patients at low vs high risk of recurrence and metastasis.”
Thanks @UroTimes + Hannah Clarke for the feature.
heyor.ca/mI71pa
#ArteraAI
3
5
624
In case you missed it: research showing that multimodal AI predicts abiraterone benefit in very high-risk #ProstateCancer is heading to print in the October issue of Annals of Oncology.
Read the full publication: buff.ly/zkVMcnp
#ArteraAI
1
1
102
At #ASCO26, Xinglei Shen, MD, discussed new research evaluating Artera’s multimodal AI biomarker in a real-world population, along with findings from a new image-only model for localized #ProstateCancer.
Watch the conversation: buff.ly/aKYVlmp
1
1
100
Artera’s Julia Ross is joining industry and regulatory leaders at the @OGPREMED CDx & #PrecisionMedicine Conference for a discussion on the evolving regulatory landscape for AI-derived biomarkers.
Attending? Add the session to your agenda: buff.ly/PL57hJ5
1
1
78
Not all men experience #ProstateCancer equally.
African American men face greater risk and mortality, yet remain underrepresented in clinical research.
This #ProstateCancerAwarenessMonth, we’re highlighting why representation matters. #MindTheGap
1
1
85
Heading to #ASTRO26?
The Artera team will be onsite and looking forward to connecting with the radiation oncology community and discussing the role of AI-powered biomarkers in #ProstateCancer care.
#ArteraOnTheGo
1
2
167
In our latest blog, Brad Macdonald goes behind the scenes of the data infrastructure Artera built to prepare thousands of gigapixel-scale pathology images for model development.
Read more: buff.ly/beVrNpP
#ArteraAI
1
1
89
We’re looking forward to connecting with the urology community at @therapy_focal and the Southern Society of Urologic Surgeons Annual Meeting this September.
If you're attending, be sure to connect with the Artera team. 👇
#ProstateCancer #Urology #ArteraOnTheGo
1
1
92
As pathology AI moves into clinical practice, validation matters.
This @pathologistmag interview explores why rigorous validation, quality control, and clinical oversight are critical to delivering AI insights clinicians can trust: buff.ly/Jg989KI
#ArteraAI
1
1
129
Next up for Artera: two opportunities to connect with the #ProstateCancer community.
📍 @MayoClinic's Radiation Oncology Education for NPs & PAs
📍 Reed M. Nesbit Urologic Society Meeting
Looking forward to a great week of learning and collaboration!
#Urology #ArteraOnTheGo
2
2
171
This #ProstateCancerAwarenessMonth, @journotwit shares his experience navigating #ProstateCancer and the importance of understanding your options.
Listen to the full episode:
Spotify: buff.ly/ctJLOWf
Apple: buff.ly/EEsZ372
1
1
130
How can AI help deliver #BreastCancer prognostic insights faster?
Artera's Calvin Chao spoke with @pathologistmag about The #ArteraAI Breast Test, digital pathology, and the future of precision oncology.
Read more: buff.ly/t6jmQq5
#BreastCancer #DigitalPathology
1
1
101
The team is headed to Roanoke and Tucson for the Mid-Atlantic and South Central @AmerUrological Annual Meetings.
Looking forward to connecting with the #Urology community!
#ProstateCancer #ArteraOnTheGo
1
1
125
This #ProstateCancerAwarenessMonth, Dr. Ben Fischer-Valuck shares his perspective on the importance of awareness, research, and the role of precision medicine in personalizing prostate cancer care.
Hear his message below.
#ProstateCancer #ArteraAI
1
2
126
How is AI helping personalize prostate cancer care?
Dr. Jason Hafron joins the Prostate Health Podcast to discuss how the #ArteraAI Prostate Test supports risk assessment, treatment planning, and shared decision-making.
Listen here: buff.ly/Ean1wtR
#ProstateCancer
1
2
144
Next stop: the Arkansas Prostate Cancer Foundation Prostate Cancer Symposium.
Looking forward to connecting with colleagues and discussing the latest advances in #ProstateCancer care.
#ArteraOnTheGo
1
119
New research in Annals of Oncology shows the potential of Artera’s multimodal AI biomarker to predict benefit from abiraterone in very high-risk, nonmetastatic #prostatecancer.
Read the study: buff.ly/uD01ZPr
#ArteraAI
1
2
179
Next stop: #NYAUA2026 🇮🇹
Looking forward to joining colleagues in Rome for a week of learning, collaboration, and conversations advancing the future of #ProstateCancer care.
#ArteraOnTheGo
1
1
121
What will drive the future of precision medicine?
Amanda Lowe shares why it's not just about more data, it's about high-quality, clinically validated data that delivers meaningful insights.
Read more: buff.ly/2LZE72w
#DigitalPathology #AIinHealthcare #ArteraAI
1
1
125